Literature for TL-3 (A02.007 inhibitor)
(Topics flags: S Structure, M Mutation, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Li,M., Gustchina,A., Matuz,K., Tozser,J., Namwong,S., Goldfarb,N.E., Dunn,B.M. and Wlodawer,A.
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
FEBS J278, 4413-4424. PubMed Europe PubMed DOI S I -
Sanches,M., Krauchenco,S., Martins,N.H., Gustchina,A., Wlodawer,A. and Polikarpov,I.
Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development
J Mol Biol369, 1029-1040. PubMed Europe PubMed DOI S I -
[YEAR:20-12-2006]Heaslet,H., Kutilek,V., Morris,G.M., Lin,Y.C., Elder,J.H., Torbett,B.E. and Stout,C.D.
Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3
J Mol Biol356, 967-981. PubMed Europe PubMed DOI S I -
[YEAR:19-11-2004]de Rozieres,S., Swan,C.H., Sheeter,D.A., Clingerman,K.J., Lin,Y.C., Huitron-Resendiz,S., Henriksen,S., Torbett,B.E. and Elder,J.H.
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3
Retrovirology1, 38-38. PubMed Europe PubMed DOI I -
Huitron-Resendiz,S., de Rozieres,S., Sanchez-Alavez,M., Buhler,B., Lin,Y.C., Lerner,D.L., Henriksen,N.W., Burudi,M., Fox,H.S., Torbett,B.E., Henriksen,S. and Elder,J.H.
Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3
J Virol78, 4525-4532. PubMed Europe PubMed DOI I -
Sanches,M., Helena Martins,N., Calazans,A., de Moraes Brindeiro,R., Tanuri,A., Antunes,O.A. and Polikarpov,I.
Crystallization of a non-B and a B mutant HIV protease
Acta Crystallogr D Biol Crystallogr60, 1625-1627. PubMed Europe PubMed DOI M S I -
[YEAR:1-1-2000]Li,M., Morris,G.M., Lee,T., Laco,G.S., Wong,C.H., Olson,A.J., Elder,J.H., Wlodawer,A. and Gustchina,A.
Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease
Proteins38, 29-40. PubMed Europe PubMed DOI I -
[YEAR:3-2-1998]Lee,T., Laco,G.S., Torbett,B.E., Fox,H.S., Lerner,D.L., Elder,J.H. and Wong,C.H.
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo
Proc Natl Acad Sci U S A95, 939-944. PubMed Europe PubMed I
2011
2007
2006
2004
2000
1998
